AI
AGIO icon

Atom Investors’s Agios Pharmaceuticals AGIO Stock Holding History

Atom Investors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,700
Closed -$550K – 240
2020
Q4 		$550K Buy
+12,700
New +$502K 0.06% 236
2019
Q1 		– Sell
-8,158
Closed -$376K – 498
2018
Q4 		$376K Buy
+8,158
New +$504K 0.04% 452

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atom Investors's AGIO Position: Q1 2021 in Review

Atom Investors sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 12,700 shares — an estimated $550K sold.

Atom Investors first reported a position in AGIO in Q4 2018 and held it in 2 quarters. The position peaked at $550K in Q4 2020. 174 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

  • Atom Investors reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Atom Investors sold 12,700 Agios Pharmaceuticals shares in Q1 2021, an estimated $550K.
  • Atom Investors first reported a position in Agios Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • Atom Investors's Agios Pharmaceuticals position peaked at $550K in Q4 2020.
  • 174 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Atom Investors's 13F filing for Q1 2021, filed 17 May 2021.